These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8370613)

  • 1. Contributions to the understanding and management of breast cancer. Steiner Award Lecture 1992.
    Fisher B
    Int J Cancer; 1993 Sep; 55(2):179-80. PubMed ID: 8370613
    [No Abstract]   [Full Text] [Related]  

  • 2. From adjuvant to neo-adjuvant chemotherapy in high-risk breast cancer: the experience of the Milan Cancer Institute. Steiner Award Lecture 1992.
    Bonadonna G
    Int J Cancer; 1993 Aug; 55(1):1-4. PubMed ID: 8344741
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Du XL
    J Natl Cancer Inst; 2003 May; 95(9):683; author reply 684-5. PubMed ID: 12734321
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term adjuvant therapy for primary breast cancer.
    Bulbrook RD
    BMJ; 1996 Feb; 312(7028):389-90. PubMed ID: 8601097
    [No Abstract]   [Full Text] [Related]  

  • 6. The changing landscape of breast cancer clinical research. ESMO-Award Lecture, ECCO-9 Hamburg, 18 September 1997.
    Piccart MJ
    Ann Oncol; 1998 Feb; 9(2):133-8. PubMed ID: 9553657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials referral resource. High priority trials--III. Breast cancer.
    Cheson BD; Ungerleider RS
    Oncology (Williston Park); 1992 Dec; 6(12):46-50. PubMed ID: 1334690
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward optimal health: the experts discuss tamoxifen and breast cancer prevention. Interview by Jodi Godfrey Meisler.
    Ford E; Greenwald P
    J Womens Health; 1998 Jun; 7(5):513-7. PubMed ID: 9650151
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Mariotto A; Feuer EJ; Harlan LC; Wun LM; Johnson KA; Abrams J
    J Natl Cancer Inst; 2002 Nov; 94(21):1626-34. PubMed ID: 12419789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Jordan VC; Morrow M
    J Natl Cancer Inst; 2003 May; 95(9):683-4; author reply 684-5. PubMed ID: 12734320
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.
    Br J Cancer; 1988 Jun; 57(6):604-7. PubMed ID: 2900646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal manipulation in the adjuvant treatment of breast cancer.
    Honig SF; Swain SM
    Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FECS Clinical Award lecture 1989. Factors in decision making in the treatment of breast cancer. Federation of European Cancer Societies.
    van der Schueren E
    Radiother Oncol; 2000 Jun; 55(3):205-16;discussion 217-8. PubMed ID: 10869736
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 2002 Oct; 94(19):1504. PubMed ID: 12359860
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemoendocrine therapy in breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1986 Apr; 4(4):451-4. PubMed ID: 3514802
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant hormonal therapy in early breast cancer.
    Kumar S; Leonard RC
    Oncology (Williston Park); 2005 Oct; 19(11):1425-8, 1433; discussion 1433-41, 1444-6. PubMed ID: 16370445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tamoxifen as treatment of breast cancer.
    Powles TJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant endocrine therapy for breast cancer.
    Rao RD; Cobleigh MA
    Oncology (Williston Park); 2012 Jun; 26(6):541-7, 550, 552 passim. PubMed ID: 22870539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.